Lexeo Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2022 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Lexeo Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2022 to Q2 2024.
  • Lexeo Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 33M shares.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 33M Jun 30, 2024 10-Q 2024-08-12
Q1 2024 32.9M Mar 31, 2024 10-Q 2024-05-09
Q4 2023 26.6M +25M +1558% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 1.63M Sep 30, 2023 10-Q 2023-12-11
Q4 2022 1.61M Dec 31, 2022 10-K 2024-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.